Magdolna Szántó

1.2k total citations
20 papers, 900 citations indexed

About

Magdolna Szántó is a scholar working on Oncology, Geriatrics and Gerontology and Immunology. According to data from OpenAlex, Magdolna Szántó has authored 20 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Geriatrics and Gerontology and 5 papers in Immunology. Recurrent topics in Magdolna Szántó's work include PARP inhibition in cancer therapy (13 papers), Sirtuins and Resveratrol in Medicine (6 papers) and Adipose Tissue and Metabolism (4 papers). Magdolna Szántó is often cited by papers focused on PARP inhibition in cancer therapy (13 papers), Sirtuins and Resveratrol in Medicine (6 papers) and Adipose Tissue and Metabolism (4 papers). Magdolna Szántó collaborates with scholars based in Hungary, France and United States. Magdolna Szántó's co-authors include Péter Bai, Borbála Kiss, Pál Gergely, Attila Brunyánszki, László Virág, Lilla Nagy, Lajos Kemény, Anikó Dózsa, Kornélia Szabó and Pál Pacher and has published in prestigious journals such as Genes & Development, PLoS ONE and Cell Metabolism.

In The Last Decade

Magdolna Szántó

19 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdolna Szántó Hungary 15 398 373 179 155 148 20 900
Edina Bakondi Hungary 16 295 0.7× 268 0.7× 33 0.2× 62 0.4× 47 0.3× 20 737
Tae‐Hwe Heo South Korea 18 191 0.5× 429 1.2× 24 0.1× 134 0.9× 99 0.7× 64 1.0k
Katie R. Martin United States 19 122 0.3× 478 1.3× 17 0.1× 151 1.0× 311 2.1× 34 1.0k
Yu Tao China 19 53 0.1× 376 1.0× 61 0.3× 97 0.6× 94 0.6× 28 786
Wenqin Xiao China 18 184 0.5× 625 1.7× 35 0.2× 34 0.2× 105 0.7× 50 1.1k
Ziyu Meng China 14 86 0.2× 281 0.8× 24 0.1× 54 0.3× 131 0.9× 35 671
Yong Zuo China 20 299 0.8× 917 2.5× 58 0.3× 79 0.5× 130 0.9× 31 1.3k
Laura Antonucci United States 9 159 0.4× 550 1.5× 15 0.1× 69 0.4× 254 1.7× 10 1.0k

Countries citing papers authored by Magdolna Szántó

Since Specialization
Citations

This map shows the geographic impact of Magdolna Szántó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdolna Szántó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdolna Szántó more than expected).

Fields of papers citing papers by Magdolna Szántó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdolna Szántó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdolna Szántó. The network helps show where Magdolna Szántó may publish in the future.

Co-authorship network of co-authors of Magdolna Szántó

This figure shows the co-authorship network connecting the top 25 collaborators of Magdolna Szántó. A scholar is included among the top collaborators of Magdolna Szántó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdolna Szántó. Magdolna Szántó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molnár, Petra, György Vereb, Magdolna Szántó, et al.. (2025). Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype. Frontiers in Immunology. 16. 1593141–1593141.
2.
Szántó, Magdolna, José Yélamos, & Péter Bai. (2024). Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1?. Expert Reviews in Molecular Medicine. 26. e13–e13. 9 indexed citations
3.
Póliska, Szilárd, Gyula Ujlaki, Máté Demény, et al.. (2023). PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes. Journal of Molecular Medicine. 101(8). 987–999. 5 indexed citations
4.
Bai, Péter, et al.. (2022). Antigen-Presenting Cells in Psoriasis. Life. 12(2). 234–234. 14 indexed citations
5.
Szántó, Magdolna, Rebecca Gupte, W. Lee Kraus, Pál Pacher, & Péter Bai. (2021). PARPs in lipid metabolism and related diseases. Progress in Lipid Research. 84. 101117–101117. 100 indexed citations
6.
Szántó, Magdolna & Péter Bai. (2020). The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism. Genes & Development. 34(5-6). 321–340. 65 indexed citations
7.
Jankó, L, Zsanett Sári, Tündé Kovàcs, et al.. (2020). Silencing of PARP2 Blocks Autophagic Degradation. Cells. 9(2). 380–380. 15 indexed citations
8.
Szántó, Magdolna, et al.. (2019). Targeting the gut‐skin axis—Probiotics as new tools for skin disorder management?. Experimental Dermatology. 28(11). 1210–1218. 124 indexed citations
9.
Kiss, Borbála, Magdolna Szántó, Csaba Hegedűs, et al.. (2019). Poly(ADP‐ribose) polymerase‐1 depletion enhances the severity of inflammation in an imiquimod‐induced model of psoriasis. Experimental Dermatology. 29(1). 79–85. 20 indexed citations
10.
Márton, Judit, Mária Péter, Gábor Balogh, et al.. (2018). Poly(ADP-ribose) polymerase-2 is a lipid-modulated modulator of muscular lipid homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(11). 1399–1412. 17 indexed citations
11.
Fodor, Tamás, Magdolna Szántó, Omar Abdul‐Rahman, et al.. (2016). Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1. PLoS ONE. 11(2). e0150232–e0150232. 51 indexed citations
12.
Abdul‐Rahman, Omar, Endre Kristóf, András Vida, et al.. (2016). AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype. PLoS ONE. 11(6). e0157644–e0157644. 29 indexed citations
13.
Kiss, Borbála, Magdolna Szántó, Attila Brunyánszki, et al.. (2014). Poly(ADP) ribose polymerase-1 ablation alters eicosanoid and docosanoid signaling and metabolism in a murine model of contact hypersensitivity. Molecular Medicine Reports. 11(4). 2861–2867. 12 indexed citations
14.
15.
Szántó, Magdolna, Attila Brunyánszki, Judit Márton, et al.. (2013). Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(4). 594–602. 38 indexed citations
16.
Szántó, Magdolna, Attila Brunyánszki, Borbála Kiss, et al.. (2012). Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein. Cellular and Molecular Life Sciences. 69(24). 4079–4092. 72 indexed citations
17.
Rutkai, Ibolya, Magdolna Szántó, Csaba Hegedűs, et al.. (2012). POLY(ADP‐RIBOSE) POLYMERASE‐2 DEPLETION REDUCES DOXORUBICIN‐INDUCED DAMAGE THROUGH SIRT1 INDUCTION. The FASEB Journal. 26(S1). 3 indexed citations
18.
Bai, Péter, Carles Cantó, Attila Brunyánszki, et al.. (2011). PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure. Cell Metabolism. 13(4). 450–460. 212 indexed citations
19.
Szántó, Magdolna, Ibolya Rutkai, Csaba Hegedűs, et al.. (2011). Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction. Cardiovascular Research. 92(3). 430–438. 54 indexed citations
20.
Brunyánszki, Attila, Csaba Hegedűs, Magdolna Szántó, et al.. (2010). Genetic Ablation of PARP-1 Protects Against Oxazolone-Induced Contact Hypersensitivity by Modulating Oxidative Stress. Journal of Investigative Dermatology. 130(11). 2629–2637. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edina Bakondi Breakdown of academic impact, for papers by Tae‐Hwe Heo Breakdown of academic impact, for papers by Katie R. Martin Breakdown of academic impact, for papers by Yu Tao Breakdown of academic impact, for papers by Wenqin Xiao Breakdown of academic impact, for papers by Ziyu Meng Breakdown of academic impact, for papers by Yong Zuo Breakdown of academic impact, for papers by Laura Antonucci
Rankless by CCL
2026